| Morgan Rich, PHARMD | |
|
910 Unity Rd, Crossett, AR 71635-9424 | |
| (870) 364-2165 | |
| Not Available |
| Full Name | Morgan Rich |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 910 Unity Rd, Crossett, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700487543 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD15446 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Rich, PHARMD 910 Unity Rd, Crossett, AR 71635-9424 Ph: (870) 364-7205 | Morgan Rich, PHARMD 910 Unity Rd, Crossett, AR 71635-9424 Ph: (870) 364-2165 |
News Archive
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
New research published today sheds important light on how the production of a key protein in the brain is controlled, which could pave the way for new treatments for a wide range of neurological conditions.
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
A recent study conducted by the National Institute of Environmental Health Sciences (NIEHS), an agency of the National Institutes of Health (NIH), shows that 32 million people in the United States have autoantibodies, the most common of which are antinuclear antibodies.
Hebrew University of Jerusalem researchers showed that when exposed to repeated cycles of antibiotics, bacteria evolved a new adaptation by remaining dormant for the treatment period. The results show for the first time that bacteria can develop a biological timer to survive under antibiotic exposure.
› Verified 4 days ago
Dr. Billy D Gammel, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Unity Rd, Crossett, AR 71635 Phone: 870-364-5100 Fax: 870-364-5120 | |
Brandon Lee Lloyd, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Unity Rd, Crossett, AR 71635 Phone: 870-364-5100 | |
Katie Ellen Land, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Unity Rd, Crossett, AR 71635 Phone: 870-364-5100 Fax: 870-364-5120 | |
Austin Rahmann Sayyar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 Unity Rd, Crossett, AR 71635 Phone: 870-364-7205 | |
Jessica Marie Long, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 Unity Rd, Crossett, AR 71635 Phone: 870-364-7205 Fax: 870-364-7207 | |
Hailey Outlaw, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Unity Rd, Crossett, AR 71635 Phone: 870-364-5100 Fax: 870-364-5120 | |
Shannon Ashley Fox, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 Unity Rd, Crossett, AR 71635 Phone: 870-364-7205 |